Literature DB >> 34157149

Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020.

Thais Silva Matos1, Vanessa Almeida do Nascimento2, Rodrigo Feliciano do Carmo3,4, Tânia Rita Moreno de Oliveira Fernandes5, Carlos Dornels Freire de Souza2, Tarcísio Fulgêncio Alves da Silva1.   

Abstract

This study analyzed the impact of the COVID-19 pandemic on the detection of new cases of leprosy in the state of Bahia, Brazil. The periods January-September 2019 and January-September 2020 were compared. There was a 44.40% reduction in the diagnosis of leprosy when comparing the two periods (1,705 in 2019 and 948 in 2020). There was a reduction in the number of municipalities with reported cases: 251 municipalities in 2019 and 202 in 2020, expressing a reduction of 24.25%. Considering only the months following the arrival of the virus (April-September), the reduction was 51.10%. An inverse correlation was observed between the number of new cases of leprosy and the cumulative number of cases of COVID-19 (Spearman's correlation coefficient = -0.840; P < 0.001) and the number of new monthly cases of COVID-19 (Spearman's correlation coefficient = -0.817; P < 0.001). A slight increase was also observed in the proportion of multibacillary cases in the state (70.38% in 2019 and 72.69% in 2020) as well as in the proportion of individuals with the degree of physical disability not assessed at diagnosis, whose proportion rose from 16.39% in 2019 to 22.53% in 2020. The negative impact of COVID-19 in tackling leprosy should be seen as a warning sign for health and political authorities.
© 2021 the International Society of Dermatology.

Entities:  

Mesh:

Year:  2021        PMID: 34157149     DOI: 10.1111/ijd.15705

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?

Authors:  Mariana do Rosário Souza; Wandklebson Silva da Paz; Vinícius Barbosa Dos Santos Sales; Gleidson Felipe Hilario de Jesus; Débora Dos Santos Tavares; Shirley V M Almeida Lima; Álvaro Francisco Lopes Sousa; Enaldo Vieira de Melo; Rodrigo Feliciano do Carmo; Carlos Dornels Freire de Souza; Márcio Bezerra-Santos
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study.

Authors:  Wandklebson Silva da Paz; Mariana do Rosário Souza; Débora Dos Santos Tavares; Amélia Ribeiro de Jesus; Allan Dantas Dos Santos; Rodrigo Feliciano do Carmo; Carlos Dornels Freire de Souza; Márcio Bezerra-Santos
Journal:  Lancet Reg Health Am       Date:  2022-01-15

3.  A time series analysis of detection and mortality of hepatitis C in Brazil, 2008-2018.

Authors:  Rodrigo José Videres Cordeiro de Brito; Leonardo Feitosa da Silva; Márcio Bezerra Santos; Patrícia Muniz Mendes Freire de Moura; Carlos Dornels Freire de Souza; Rodrigo Feliciano do Carmo
Journal:  BMC Infect Dis       Date:  2022-01-24       Impact factor: 3.090

4.  Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

Authors:  Rodrigo Feliciano do Carmo; Carlos Dornels Freire de Souza
Journal:  J Hepatol       Date:  2021-08-24       Impact factor: 25.083

Review 5.  Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19.

Authors:  Jéssica Araujo da Paixão de Oliveira; Mariana Martins de Athaide; Atta Ur Rahman; Mayara Garcia de Mattos Barbosa; Marcia Maria Jardim; Milton Ozório Moraes; Roberta Olmo Pinheiro
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.